Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Minority K65R Variants and Early Failure of Antiretroviral Therapy in HIV-1–infected Eritrean Immigrant
  • Published Date:
    Oct 2011
  • Source:
    Emerg Infect Dis. 17(10):1966-1968.
Filetype[PDF-231.99 KB]


No Related Documents.
You May Also Like:
  1. Zoonotic Ascariasis, United Kingdom
    Personal Author:
    Bendall, Richard P.; Barlow, Maggie; Betson, Martha; Stothard, J. Russell; Nejsum, Peter;
    Published Date:
    Oct 2011
    Source:
    Emerg Infect Dis. 17(10):1964-1966.
    File Type:
    Filetype[PDF - 199.56 KB]
  2. Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy
    Personal Author:
    Nishizawa, Masako; Matsuda, Masakazu; Hattori, Junko; Shiino, Teiichiro; Matano, Tetsuro; Heneine, Walid; Johnson, Jeffrey A.; Sugiura, Wataru;
    Published Date:
    Sep 11 2015
    Source:
    PLoS One. 10(9).
    Description:
    BackgroundDrug-resistant HIV are more prevalent and persist longer than previously demonstrated by bulk sequencing due to the ability to detect low-frequency variants. To clarify a clinical benefit to monitoring minority-level drug resistance populat...
    File Type:
    Filetype[PDF - 1.26 MB]
  3. Highly-Sensitive Allele-Specific PCR Testing Identifies a Greater Prevalence of Transmitted HIV Drug Resistance in Japan
    Personal Author:
    Nishizawa, Masako; Hattori, Junko; Shiino, Teiichiro; Matano, Tetsuro; Heneine, Walid; Johnson, Jeffrey A.; Sugiura, Wataru;
    Published Date:
    Dec 16 2013
    Source:
    PLoS One. 2013; 8(12).
    Description:
    BackgroundThe transmission of drug-resistant HIV in newly identified infected populations has become an underlying epidemic which can be better assessed with sensitive resistance testing. Since minority drug resistant variants cannot be detected by b...
    File Type:
    Filetype[PDF - 582.33 KB]
  4. Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy
    Personal Author:
    Zhou, Zhiyong; Tang, Kevin; Zhang, Guoqing; Wadonda-Kabondo, Nellie; Moyo, Kundai; Rowe, Lori A.; DeVos, Joshua R.; Wagar, Nick; Zheng, Du-Ping; Guo, Hongxiong; Nkengasong, John; Frace, Mike; Sammons, Scott; Yang, Chunfu;
    Published Date:
    May 30 2018
    Source:
    Afr J Lab Med. 2018; 7(1).
    Description:
    BackgroundMinority drug resistance mutations (DRMs) that are often missed by Sanger sequencing are clinically significant, as they can cause virologic failure in individuals treated with antiretroviral therapy (ART) drugs.ObjectiveThis study aimed to...
    File Type:
    Filetype[PDF - 2.60 MB]
  5. Simple PCR Assays Improve the Sensitivity of HIV-1 Subtype B Drug Resistance Testing and Allow Linking of Resistance Mutations
    Personal Author:
    Johnson, Jeffrey A.; Li, Jin-Fen.; Wei, Xierong; Lipscomb, Jonathan.; Bennett, Diane.; Brant, Ashley.; Cong, Mian-er.; Spira, Thomas.; Shafer, Robert W.; Heneine, Walid.;
    Published Date:
    Jul 25 2007
    Source:
    PLoS ONE. 2007; 2(7).
    Description:
    BackgroundThe success of antiretroviral therapy is known to be compromised by drug-resistant HIV-1 at frequencies detectable by conventional bulk sequencing. Currently, there is a need to assess the clinical consequences of low-frequency drug resista...
    File Type:
    Filetype[PDF - 321.52 KB]